Our study also found that reducing or inhibiting HDAC7 can alleviate synaptic impairments and cognitive deficits in PS19 mice, providing further support for the therapeutic potential of HDAC7 suppression in promoting astrocyte-mediated clearance of tau pathology. The gene discussed is HDAC7; the disease is Cognitive impairment.